396 related articles for article (PubMed ID: 19151038)
1. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
2. Macrolide and ketolide resistance with Streptococcus pneumoniae.
Doern GV
Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
[TBL] [Abstract][Full Text] [Related]
3. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones.
Fenoll A; Giménez MJ; Robledo O; Coronel P; Gimeno M; Casal J; Aguilar L
Int J Antimicrob Agents; 2007 Feb; 29(2):224-6. PubMed ID: 17175141
[No Abstract] [Full Text] [Related]
4. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
7. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
Choi SH; Park SJ; Jun JB; Lee SR; Jeon MH; Kwon HH; Kim SC; Kim MN; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2007 May; 58(1):141-3. PubMed ID: 17368803
[TBL] [Abstract][Full Text] [Related]
9. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
Inoue M; Kaneko K; Nakano R; Sato Y; Arai S
Jpn J Antibiot; 2004 Oct; 57(5):425-37. PubMed ID: 15655904
[TBL] [Abstract][Full Text] [Related]
10. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
Martynova AV; Turcutyuicov VB
Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139
[No Abstract] [Full Text] [Related]
12. Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.
Drago L; Nicola L; Rodighiero V; Larosa M; Mattina R; De Vecchi E
J Antimicrob Chemother; 2011 Apr; 66(4):845-9. PubMed ID: 21393187
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia.
Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W
J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511
[No Abstract] [Full Text] [Related]
15. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
Nuermberger E; Bishai WR
Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455
[TBL] [Abstract][Full Text] [Related]
16. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003).
Schito GC; Felmingham D
Int J Antimicrob Agents; 2005 Dec; 26(6):479-85. PubMed ID: 16289710
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
J Antimicrob Chemother; 2008 Nov; 62(5):1156-8. PubMed ID: 18667449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
